Shanghai Haoyuan Chemexpress Co., Ltd. (SHA:688131)
China · Delayed Price · Currency is CNY 73.00
+1.32 (1.84%)
Apr 28, 2026, 3:00 PM CST
SHA:688131 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 2,877 | 2,254 | 1,868 | 1,348 | 969.23 |
Other Revenue | - | 16.5 | 11.69 | 9.77 | - |
| 2,877 | 2,270 | 1,880 | 1,358 | 969.23 | |
Revenue Growth (YoY) | 26.73% | 20.75% | 38.44% | 40.12% | 52.61% |
Cost of Revenue | 1,522 | 1,311 | 1,113 | 702.2 | 473.74 |
Gross Profit | 1,355 | 959.67 | 766.71 | 655.85 | 495.49 |
Selling, General & Admin | 602.09 | 444.9 | 378.18 | 279.2 | 183.67 |
Research & Development | 237.62 | 226.93 | 224.12 | 201.58 | 103.45 |
Other Operating Expenses | -13.31 | 9.47 | 4.94 | 5.11 | 2.73 |
Operating Expenses | 826.39 | 696.26 | 618.1 | 497.11 | 293.71 |
Operating Income | 528.73 | 263.41 | 148.61 | 158.74 | 201.78 |
Interest Expense | - | -44 | -33.9 | -16.86 | -9.5 |
Interest & Investment Income | - | 7.48 | 3.21 | 25.76 | 12.65 |
Currency Exchange Gain (Loss) | - | 7.59 | 3.55 | 10.47 | -6.38 |
Other Non Operating Income (Expenses) | -103.77 | -9.09 | -7.62 | -4.36 | -3.69 |
EBT Excluding Unusual Items | 424.96 | 225.39 | 113.85 | 173.75 | 194.86 |
Gain (Loss) on Sale of Investments | -15.89 | -13.61 | -4.77 | - | -0.12 |
Gain (Loss) on Sale of Assets | 0.79 | -0.57 | 0.06 | -0.19 | -0.04 |
Asset Writedown | -134.09 | - | - | - | - |
Other Unusual Items | - | 27.14 | 19.05 | 24.99 | 14.81 |
Pretax Income | 275.78 | 238.36 | 128.19 | 198.54 | 209.52 |
Income Tax Expense | 44.13 | 40.43 | 1.88 | 6.99 | 18.95 |
Earnings From Continuing Operations | 231.65 | 197.93 | 126.31 | 191.56 | 190.57 |
Minority Interest in Earnings | 8.16 | 3.66 | 1.14 | 2.09 | 0.41 |
Net Income | 239.81 | 201.59 | 127.45 | 193.64 | 190.98 |
Net Income to Common | 239.81 | 201.59 | 127.45 | 193.64 | 190.98 |
Net Income Growth | 18.96% | 58.17% | -34.18% | 1.40% | 48.70% |
Shares Outstanding (Basic) | 212 | 210 | 209 | 204 | 178 |
Shares Outstanding (Diluted) | 212 | 210 | 209 | 204 | 178 |
Shares Change (YoY) | 1.06% | 0.51% | 2.50% | 14.35% | 16.33% |
EPS (Basic) | 1.13 | 0.96 | 0.61 | 0.95 | 1.07 |
EPS (Diluted) | 1.13 | 0.96 | 0.61 | 0.95 | 1.07 |
EPS Growth | 17.71% | 57.38% | -35.79% | -11.33% | 27.82% |
Free Cash Flow | 95.96 | 77.5 | -323.37 | -821.59 | -229.85 |
Free Cash Flow Per Share | 0.45 | 0.37 | -1.55 | -4.03 | -1.29 |
Dividend Per Share | - | 0.190 | 0.107 | 0.194 | 0.193 |
Dividend Growth | - | 77.40% | -44.77% | 0.41% | - |
Gross Margin | 47.10% | 42.27% | 40.78% | 48.29% | 51.12% |
Operating Margin | 18.38% | 11.60% | 7.90% | 11.69% | 20.82% |
Profit Margin | 8.34% | 8.88% | 6.78% | 14.26% | 19.70% |
Free Cash Flow Margin | 3.34% | 3.41% | -17.20% | -60.50% | -23.71% |
EBITDA | 648.64 | 381.99 | 232.05 | 195.23 | 217.57 |
EBITDA Margin | 22.55% | 16.83% | 12.34% | 14.38% | 22.45% |
D&A For EBITDA | 119.91 | 118.58 | 83.43 | 36.49 | 15.79 |
EBIT | 528.73 | 263.41 | 148.61 | 158.74 | 201.78 |
EBIT Margin | 18.38% | 11.60% | 7.90% | 11.69% | 20.82% |
Effective Tax Rate | 16.00% | 16.96% | 1.47% | 3.52% | 9.04% |
Revenue as Reported | - | 2,270 | 1,880 | 1,358 | 969.23 |
Advertising Expenses | - | 61.5 | 37.99 | 23.61 | 16.79 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.